Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New DNA testing scheme for one of Britain's rarest dogs
Otterhound breed numbers are very low.

Scheme tests for Glanzmann’s thrombasthenia in the otterhound.

A new DNA testing scheme for one of the UK's rarest dog breeds has been approved by the Kennel Club.

The official scheme tests for Glanzmann’s thrombasthenia (GT) in the otterhound - a breed which saw a mere 44 puppy registrations in 2019, and is listed by the Kennel Club as a 'Vulnerable British Breed'.

It is hoped the test will combat inherited disease in otterhounds by enabling breeders to make more informed choices when deciding to breed a litter.

Breed health coordinator, Judith Ashworth, said: “The otterhound is basically a very healthy breed. However, as their numbers are very low, breeders need every assistance they can get when it comes to ensuring the breed is preserved for future generations, partly through breeding interaction across the world.”

GT is an inherited blood-clotting disorder characterised in dogs by bruising, frequent bleeding from the nose and blood in the urine and/or stools. Dogs with the condition normally show signs before the age of one, often by bleeding from the gums as their adult teeth emerge.

To acquire the condition, a dog must inherit two copies of an abnormal gene, one from its mother and one from its father, before its health is affected. A dog that inherits one copy of an abnormal gene will have no signs of the disease, but will be a carrier and may pass the gene on to any offspring.

Dogs that undergo the Kennel Club's GT test will be classed as either:

Clear
The dog does not have any copies of the abnormal gene associated with GT. The dog is highly unlikely to be clinically affected and will pass on only a normal copy of the gene to a puppy.

Carrier
The dog has one copy of the normal gene and one copy of the abnormal gene associated with GT. The dog is unlikely to be clinically affected but may pass on one copy of the normal gene, or one copy of the abnormal gene, to a puppy.

Affected
The dog has two copies of the abnormal gene associated with GT. The dog will be clinically affected by the disorder and will pass on one copy of the abnormal gene to any potential offspring.

Test results will be added to the dog’s registration details which will trigger the publication of the result in the next available Breed Records Supplement. The result will appear on any new registration certificate issued for the dog and on the registration certificates of any future progeny of the dog, and also on the Health Test Results Finder on the Kennel Club website.

To find out which laboratories the Kennel Club can record results from, and which labs will send results direct to the Kennel Club, please refer to the worldwide DNA testing list at thekennelclub.org.uk

Image (C) Kennel Club.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.